These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22916251)

  • 1. Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice.
    Al-Wadei HA; Al-Wadei MH; Ullah MF; Schuller HM
    PLoS One; 2012; 7(8):e43376. PubMed ID: 22916251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.
    Al-Wadei HA; Plummer HK; Schuller HM
    Carcinogenesis; 2009 Mar; 30(3):506-11. PubMed ID: 19131543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer.
    Al-Wadei HA; Plummer HK; Ullah MF; Unger B; Brody JR; Schuller HM
    Cancer Prev Res (Phila); 2012 Feb; 5(2):189-96. PubMed ID: 21955519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
    Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.
    Schuller HM; Al-Wadei HA; Ullah MF; Plummer HK
    Carcinogenesis; 2012 Jan; 33(1):191-6. PubMed ID: 22072614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA B receptor is a novel drug target for pancreatic cancer.
    Schuller HM; Al-Wadei HA; Majidi M
    Cancer; 2008 Feb; 112(4):767-78. PubMed ID: 18098271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
    Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
    Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W; Yu CH; Hu KQ
    Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
    Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-amino butyric acid (GABA) prevents the induction of nicotinic receptor-regulated signaling by chronic ethanol in pancreatic cancer cells and normal duct epithelia.
    Al-Wadei MH; Al-Wadei HA; Schuller HM
    Cancer Prev Res (Phila); 2013 Feb; 6(2):139-48. PubMed ID: 23213073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    Ding N; Cui XX; Gao Z; Huang H; Wei X; Du Z; Lin Y; Shih WJ; Rabson AB; Conney AH; Hu C; Zheng X
    Int J Oncol; 2014 Jun; 44(6):2139-45. PubMed ID: 24647860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
    Lin X; Luo K; Lv Z; Huang J
    Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.
    Ding X; Zhu C; Qiang H; Zhou X; Zhou G
    Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
    Blanquicett C; Saif MW; Buchsbaum DJ; Eloubeidi M; Vickers SM; Chhieng DC; Carpenter MD; Sellers JC; Russo S; Diasio RB; Johnson MR
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8773-81. PubMed ID: 16361565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides.
    Banerjee J; Papu John AM; Schuller HM
    Int J Cancer; 2015 Dec; 137(12):2815-24. PubMed ID: 26088878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.